Logotype for Atai Life Sciences N.V.

Atai Life Sciences (ATAI) investor relations material

Atai Life Sciences Jefferies London Healthcare Conference 2025 summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Atai Life Sciences N.V.
Jefferies London Healthcare Conference 2025 summary20 Nov, 2025

Differentiation and recent developments

  • Focus on short-duration psychedelic treatments, aiming for protocols similar to Spravato, with recent merger forming AtaiBeckley.

  • Emphasis on simple administration and reduced patient/provider time commitment compared to other psychedelics.

  • Issued patents in the US, including broad claims on transmucosal delivery.

Clinical milestones and pipeline

  • End-of-phase II meeting request submitted for BPL-003; guidance on results expected Q1 next year.

  • Phase III trials for BPL-003 planned to initiate in Q2 next year, pending regulatory feedback.

  • EMP-01 phase II-A trial in social anxiety disorder completed enrollment; top-line results expected Q1 2026.

  • VLS-01 phase II-B trial in treatment-resistant depression to report results in the second half of 2026.

BPL-003 efficacy, dosing, and safety

  • Phase II-B data showed no reduction in efficacy or durability despite shorter psychedelic duration.

  • Remission rates of 65-70% at month four; comparable or better than other treatments in similar populations.

  • Anticipated average of 4-6 doses per year, less frequent than Spravato's induction and maintenance protocols.

  • Safety profile consistent with class, mostly mild/moderate adverse events; careful monitoring for suicidality.

How does BPL-003 dosing profile impact market adoption
BPL-003: Expedite approval strategy with FDA
What defines high-quality EMP-01 efficacy data?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Atai Life Sciences earnings date

Logotype for Atai Life Sciences N.V.
Q4 202523 Mar, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Atai Life Sciences earnings date

Logotype for Atai Life Sciences N.V.
Q4 202523 Mar, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Atai Life Sciences N.V. is a clinical-stage biopharmaceutical company focusing on the acquisition, incubation, and development of therapeutics aimed at treating a range of mental health disorders such as depression, anxiety, addiction, among others. The company is developing a decentralized platform approach to expedite the development of effective mental health treatments. The company is headquartered in Berlin, Germany, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage